1000 MYLAN BOULEVARD, CANONSBURG, PA
Annual Report to Security Holders
Reports Fourth-Quarter and Full-Year 2025 Financial Results
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
2025 Annual Meeting Results; Director Elections and Compensation Approved
Amended material disclosure
Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
Viatris Inc. Approves Amended and Restated Bylaws
FY 2024
Q3
Q2
Q1
Amended Annual Report
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party